Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...
Abstract: The cybersecurity of microgrid has received widespread attentions due to the frequently reported attack accidents against distributed energy resource (DER) manufactures. Numerous impact ...
Salt Lake City, Utah, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results